Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Bartlett, MD
Division of Infectious Diseases, Duke University Medical Center
Study Chair - Nagalingeswaran Kumarasamy, MBBS, PhD
Y. R. Gaitonde Centre for AIDS Research and Education
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Y.R.G Ctr, for Aids Research and Education (11701)
Chennai, India
- University of North Carolina Lilongwe Crs (12001)
Lilongwe, Malawi
- Wits Hiv Crs (11101)
Johannesburg, Gauteng, South Africa
- Kilimanjaro Christian Medical Crs
Moshi, Tanzania
- Chiang Mai University Actg Crs (11501)
Chiang Mai, Thailand
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2008
- Primary completion
- 31 Oct 2010
- Completion
- 31 May 2012
- Last update posted
- 20 Mar 2018
- Registered enrollment
- 123
- Registry id
- NCT00357552
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.